These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 34030154)
1. Human Immunodeficiency Virus and Hepatitis C Linkage-to-Care Initiative for New Orleans Residents Experiencing Homelessness During the COVID-19 Pandemic. Cironi KA; Jones AT; Hauser EM; Olsen JW; Kissinger PJ Sex Transm Dis; 2021 Aug; 48(8):595-600. PubMed ID: 34030154 [TBL] [Abstract][Full Text] [Related]
2. Viral blood-borne infections testing and linkage to care cascade among persons who experience homelessness in the United States: a systematic review and meta-analysis. Saha R; Miller AP; Parriott A; Horvath H; Kahn JG; Malekinejad M BMC Public Health; 2022 Jul; 22(1):1421. PubMed ID: 35883158 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review. Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081 [TBL] [Abstract][Full Text] [Related]
5. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan. Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston. Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823 [TBL] [Abstract][Full Text] [Related]
7. HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study. Ryan P; Valencia J; Cuevas G; Troya J; Torres-Macho J; Muñoz-Gómez MJ; Muñoz-Rivas N; Canorea I; Vázquez-Morón S; Resino S Infect Dis Poverty; 2021 Aug; 10(1):111. PubMed ID: 34412695 [TBL] [Abstract][Full Text] [Related]
8. A qualitative investigation of organizational challenges and facilitators to screening individuals experiencing homelessness for hepatitis C virus (HCV) in Houston, Texas. Celeste-Villalvir A; Wilkerson JM; Markham C; Rodriguez L; Schick V PLoS One; 2022; 17(8):e0273302. PubMed ID: 35994438 [TBL] [Abstract][Full Text] [Related]
9. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department. Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans. Noska AJ; Belperio PS; Loomis TP; O'Toole TP; Backus LI Clin Infect Dis; 2017 Jul; 65(2):252-258. PubMed ID: 28379316 [TBL] [Abstract][Full Text] [Related]
11. Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C. Conti J; Dryden E; Fincke BG; Dunlap S; McInnes DK J Gen Intern Med; 2023 Jan; 38(1):156-164. PubMed ID: 35879538 [TBL] [Abstract][Full Text] [Related]
12. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California. Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602 [TBL] [Abstract][Full Text] [Related]
13. Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus. Bar N; Bensoussan N; Rabinowich L; Levi S; Houri I; Ben-Ami Shor D; Shibolet O; Mor O; Weitzman E; Turner D; Katchman H Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429957 [TBL] [Abstract][Full Text] [Related]
14. Telemonitoring of the Continuum of Care of Hepatitis C During the COVID-19 Pandemic in Brazil. Bittencourt PL; Codes L; César AMDG; Mussi FC; Ferraz MLG Telemed J E Health; 2023 Nov; 29(11):1673-1678. PubMed ID: 36888957 [No Abstract] [Full Text] [Related]
15. Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population. McGonigle K; Carley T; Hoff C J Racial Ethn Health Disparities; 2018 Oct; 5(5):1052-1058. PubMed ID: 29288470 [TBL] [Abstract][Full Text] [Related]
16. Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons. Thompson VV; Ragland KE; Hall CS; Morgan M; Bangsberg DR AIDS; 2005 Oct; 19 Suppl 3():S208-14. PubMed ID: 16251820 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study. Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785 [TBL] [Abstract][Full Text] [Related]
18. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington. Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152 [TBL] [Abstract][Full Text] [Related]
19. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade. Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study. Kovari H; Rauch A; Kouyos R; Rougemont M; Cavassini M; Schmid P; Stöckle M; Bernasconi E; Weber R; Ledergerber B; Clin Infect Dis; 2017 Feb; 64(4):490-497. PubMed ID: 28172403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]